These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16933096)

  • 1. Percolative transport and cluster diffusion near and below the percolation threshold of a porous polymeric matrix.
    Hastedt JE; Wright JL
    Pharm Res; 2006 Oct; 23(10):2427-40. PubMed ID: 16933096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling of aqueous transport in rigid porous matrices near the percolation threshold.
    Ellis SR; Wright JL
    Pharm Res; 2006 Oct; 23(10):2441-53. PubMed ID: 16933095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion in porous materials above the percolation threshold.
    Hastedt JE; Wright JL
    Pharm Res; 1990 Sep; 7(9):893-901. PubMed ID: 2235887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of polymer content on early gel-layer formation in HPMC matrices: The use of CLSM visualisation to identify the percolation threshold.
    Mason LM; Campiñez MD; Pygall SR; Burley JC; Gupta P; Storey DE; Caraballo I; Melia CD
    Eur J Pharm Biopharm; 2015 Aug; 94():485-92. PubMed ID: 26143369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical points in ethylcellulose matrices: influence of the polymer, drug and filler properties.
    Cifuentes C; Aguilar-de-Leyva A; Rajabi-Siahboomi AR; Caraballo I
    Acta Pharm; 2013 Mar; 63(1):115-29. PubMed ID: 23482317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of percolation theory in the study of an extended release Verapamil hydrochloride formulation.
    Gonçalves-Araújo T; Rajabi-Siahboomi AR; Caraballo I
    Int J Pharm; 2008 Sep; 361(1-2):112-7. PubMed ID: 18621491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of polymer properties on direct compression and drug release from water-insoluble controlled release matrix tablets.
    Grund J; Koerber M; Walther M; Bodmeier R
    Int J Pharm; 2014 Jul; 469(1):94-101. PubMed ID: 24746409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the critical points and the role of the pores and viscosity in carbamazepine hydrophilic matrix tablets.
    Aguilar-de-Leyva A; Cifuentes C; Rajabi-Siahboomi AR; Caraballo I
    Eur J Pharm Biopharm; 2012 Jan; 80(1):136-42. PubMed ID: 21946473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational estimation of the optimum amount of non-fibrous disintegrant applying percolation theory for binary fast disintegrating formulation.
    Krausbauer E; Puchkov M; Betz G; Leuenberger H
    J Pharm Sci; 2008 Jan; 97(1):529-41. PubMed ID: 17879295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictability of drug release from water-insoluble polymeric matrix tablets.
    Grund J; Körber M; Bodmeier R
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):650-5. PubMed ID: 23985775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of the percolation thresholds in acyclovir hydrophilic matrix tablets.
    Fuertes I; Miranda A; Millán M; Caraballo I
    Eur J Pharm Biopharm; 2006 Nov; 64(3):336-42. PubMed ID: 16876392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release behaviour of clozapine matrix pellets based on percolation theory.
    Aguilar-de-Leyva A; Sharkawi T; Bataille B; Baylac G; Caraballo I
    Int J Pharm; 2011 Feb; 404(1-2):133-41. PubMed ID: 21094234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix type controlled release systems: I. Effect of percolation on drug dissolution kinetics.
    Bonny JD; Leuenberger H
    Pharm Acta Helv; 1991; 66(5-6):160-4. PubMed ID: 1784581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymer Percolation Threshold in Multi-Component HPMC Matrices Tablets.
    Maghsoodi M; Barghi L
    Adv Pharm Bull; 2011; 1(1):27-33. PubMed ID: 24312753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the drug/excipient particle size ratio in the percolation model for tablets.
    Millán M; Caraballo I; Rabasco AM
    Pharm Res; 1998 Feb; 15(2):216-20. PubMed ID: 9523306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the influence of particle size on the excipient percolation thresholds of HPMC hydrophilic matrix tablets.
    Miranda A; Millán M; Caraballo I
    J Pharm Sci; 2007 Oct; 96(10):2746-56. PubMed ID: 17506514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of isoniazid release from poly(d,l-lactide-co-glycolide) matrices prepared by dry-mixing and low density polymeric foam methods.
    Hsu YY; Gresser JD; Stewart RR; Trantolo DJ; Lyons CM; Simons GA; Gangadharam PR; Wise DL
    J Pharm Sci; 1996 Jul; 85(7):706-13. PubMed ID: 8818994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A unified multicomponent stress-diffusion model of drug release from non-biodegradable polymeric matrix tablets.
    Salehi A; Zhao J; Cabelka TD; Larson RG
    J Control Release; 2016 Feb; 224():43-58. PubMed ID: 26763374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of the percolation thresholds in lobenzarit disodium native dextran matrix tablets.
    Gil EC; Colarte AI; Bataille B; Caraballo I
    AAPS PharmSciTech; 2007 Dec; 8(4):E115. PubMed ID: 18181536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of the percolation thresholds in dextromethorphan hydrobromide matrices.
    Melgoza LM; Rabasco AM; Sandoval H; Caraballo I
    Eur J Pharm Sci; 2001 Feb; 12(4):453-9. PubMed ID: 11231112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.